These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20132158)

  • 21. Validation of capillary zone electrophoresis and capillary isoelectric focusing separations optimized for the characterization of two recombinant products of the birch pollen allergen Bet v 1a.
    Kronsteiner B; Dullnig V; Stutz H
    Electrophoresis; 2008 Jun; 29(12):2539-49. PubMed ID: 18512676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of birch recombinant allergens (rBet v 1, profilin rBet v 2) in children with pollen-related food allergy.
    Cudowska B; Kaczmarski M
    Rocz Akad Med Bialymst; 2004; 49():111-5. PubMed ID: 15631325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of IgE-binding to Art v 1, Art v 4 and Amb a 1 in mugwort-allergic patients.
    Oberhuber C; Ma Y; Wopfner N; Gadermaier G; Dedic A; Niggemann B; Maderegger B; Gruber P; Ferreira F; Scheiner O; Hoffmann-Sommergruber K
    Int Arch Allergy Immunol; 2008; 145(2):94-101. PubMed ID: 17823540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Air pollutants enhance rhinoconjunctivitis symptoms in pollen-allergic individuals.
    Riediker M; Monn C; Koller T; Stahel WA; Wüthrich B
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):311-8. PubMed ID: 11686424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogeneity of commercial timothy grass pollen extracts.
    Focke M; Marth K; Flicker S; Valenta R
    Clin Exp Allergy; 2008 Aug; 38(8):1400-8. PubMed ID: 18564332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of allergen composition and in vivo immunogenicity of depigmented allergoids of Betula alba.
    Carnés J; Himly M; Gallego M; Iraola V; Robinson DS; Fernández-Caldas E; Briza P
    Clin Exp Allergy; 2009 Mar; 39(3):426-34. PubMed ID: 19134021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification of the major group 1 allergen from Bahia grass pollen, Pas n 1.
    Drew AC; Davies JM; Dang TD; Rolland JM; O'Hehir RE
    Int Arch Allergy Immunol; 2011; 154(4):295-8. PubMed ID: 20962534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fifty percent of pollinosis patients sensitive to birch pollen demonstrate bronchoconstriction during bronchial provocation test with the allergen].
    Swiebocka E; Siergiejko Z; Siergiejko G; Leoniuk A; Hofman J
    Pol Merkur Lekarski; 2008 Jun; 24(144):492-4. PubMed ID: 18702328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and in-house validation of an allergen-specific ELISA for quantification of Bet v 4 in diagnostic and therapeutic birch allergen products.
    Dehus O; Zimmer J; Döring S; Führer F; Hanschmann KM; Holzhauser T; Neske F; Strecker D; Trösemeier JH; Vieths S; Kaul S
    Anal Bioanal Chem; 2015 Feb; 407(6):1673-83. PubMed ID: 25572690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin G4-antibodies to rBet v 1 and risk of sensitization and atopic disease in the child.
    Kihlström A; Hedlin G; Pershagen G; Troye-Blomberg M; Härfast B; Lilja G
    Clin Exp Allergy; 2005 Dec; 35(12):1542-9. PubMed ID: 16393319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives.
    Purohit A; Niederberger V; Kronqvist M; Horak F; Grönneberg R; Suck R; Weber B; Fiebig H; van Hage M; Pauli G; Valenta R; Cromwell O
    Clin Exp Allergy; 2008 Sep; 38(9):1514-25. PubMed ID: 18564326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccination of nonallergic individuals with recombinant hypoallergenic fragments of birch pollen allergen Bet v 1: Safety, effects, and mechanisms.
    Campana R; Marth K; Zieglmayer P; Weber M; Lupinek C; Zhernov Y; Elisyutina O; Khaitov M; Rigler E; Westritschnig K; Berger U; Wolkersdorfer M; Horak F; Horak F; Valenta R
    J Allergy Clin Immunol; 2019 Mar; 143(3):1258-1261. PubMed ID: 30471304
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch.
    Cudowska B; Kaczmarski M; Restani P
    Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season.
    Grindebacke H; Wing K; Andersson AC; Suri-Payer E; Rak S; Rudin A
    Clin Exp Allergy; 2004 Sep; 34(9):1364-72. PubMed ID: 15347368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-level expression and purification of the major birch pollen allergen, Bet v 1.
    Hoffmann-Sommergruber K; Susani M; Ferreira F; Jertschin P; Ahorn H; Steiner R; Kraft D; Scheiner O; Breiteneder H
    Protein Expr Purif; 1997 Feb; 9(1):33-9. PubMed ID: 9116499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody profiles and self-reported symptoms to pollen-related food allergens in grass pollen-allergic patients from northern Europe.
    Ghunaim N; Grönlund H; Kronqvist M; Grönneberg R; Söderström L; Ahlstedt S; van Hage-Hamsten M
    Allergy; 2005 Feb; 60(2):185-91. PubMed ID: 15647039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonallergic individuals recognize the same T cell epitopes of Bet v 1, the major birch pollen allergen, as atopic patients.
    Ebner C; Schenk S; Najafian N; Siemann U; Steiner R; Fischer GW; Hoffmann K; Szépfalusi Z; Scheiner O; Kraft D
    J Immunol; 1995 Feb; 154(4):1932-40. PubMed ID: 7530747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation.
    Möbs C; Slotosch C; Löffler H; Jakob T; Hertl M; Pfützner W
    J Immunol; 2010 Feb; 184(4):2194-203. PubMed ID: 20048125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
    Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
    Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.